Price History
Feb 9, 2026 — May 5, 2026Investment Snapshot
- P/E of 84.4 — elevated valuation multiple
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -83,602.7%
- Revenue declining 38% annually
Core Scientific, Inc. - Common Stock (CORZ) is a Financial Services company operating in Finance Services, listed on the NASDAQ , with a market capitalisation of $6.7 billion . Key value metrics: P/E ratio 84.4, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Core Scientific, Inc. - Common Stock — Fundamental Analysis Summary
Core Scientific, Inc. - Common Stock (CORZ) trades at a trailing P/E of 84.4x — 337% above the Financial Services sector average of 19.3x.
On financial health, CORZ shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -83,602.7% (sector average: 4.9%).
StockPik's composite Value Score for CORZ is 30/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
CORZ reports a thin gross margin of 5.1% (sector average: 9.8%) and a negative operating margin of -57.3%.
CORZ shows revenue declining at 38% year-over-year, with earnings growing at 78%.